Therapeutic Targeting of Signaling Pathways in Abdominal Aortic Aneurysm: From Pathogenesis to Precision Medicine
Imran Ibrahim Shaikh, Shekhar Singh, Yuling Feng, Khawar Ali Shahzad, Jianfeng Wang, Quan Zhou, Shuanghu Wang, Chunlai Zeng, Chuxiao Shao · 2025
Read Therapeutic Targeting of Signaling Pathways in Abdominal Aortic Aneurysm: From Pathogenesis to Precision Medicine by Imran Ibrahim Shaikh, Shekhar Singh, Yuling Feng, Khawar Ali Shahzad, Jianfeng Wang, Quan Zhou, Shuanghu Wang, Chunlai Zeng, Chuxiao Shao (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12765943.txt.
Description
Imran Ibrahim Shaikh and eight co-authors review, in 2025 work, signal paths as drug marks for a bulge of the belly aorta. Such bulges can burst and kill, and surgery is near the sole fix, since birth paths stay half-known. Flare sits at the core: wall rework, guard cell rush, and muscle cell flaw.
Some paths fan the ill — four named chains — while three shield it. Two more play both sides by scene. Fresh arms eyed span gene-good drugs, grain-borne drug runs, and stem cell care. The team frames a path from cut-only care to drug-first guard.
Catalog record
| CREATOR | Imran Ibrahim Shaikh, Shekhar Singh, Yuling Feng, Khawar Ali Shahzad, Jianfeng Wang, Quan Zhou, Shuanghu Wang, Chunlai Zeng, Chuxiao Shao |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 108 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |